Tenders for the Procurement of Medical Devices: Adapting Cost-Effectiveness Rules to the Requirements of the European Public Procurement Directive

被引：0
|
作者：
Andrea Messori
Sabrina Trippoli
Erminia Caccese
Claudio Marinai
机构：
[1] HTA Unit,
[2] ESTAR and University of Florence,undefined
[3] Regional Health System,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2020年 / 54卷
关键词：
tender; medical devices; health economics; incremental cost-effectiveness ratio; net monetary benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：226 / 231
页数：5
相关论文
共 50 条
  • [41] Incremental Cost-Effectiveness Ratio and Net Monetary Benefit Promoting the Application of Value-Based Pricing to Medical Devices-A European Perspective
    Messori, Andrea
    Trippoli, Sabrina
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (06) : 755 - 756
  • [42] Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system
    Bahia, Luciana Ribeiro
    Araujo, Denizar Vianna
    Pepe, Camila
    Trindade, Michelle
    Camargo, Caroline Mendonca
    Javaroni, Valter
    [J]. INTERNATIONAL BRAZ J UROL, 2012, 38 (05): : 595 - 605
  • [43] Healthcare cost-effectiveness evaluations: comparing and contrasting methods for pharmaceuticals, medical devices and digital health technologies
    Malcolm, Robert
    Naylor, Rebecca
    Holmes, Hayden
    [J]. MEDICAL DECISION MAKING, 2024, 44 (02) : NP64 - NP65
  • [44] EN 301 549: Parameter decoding, evolution and translation into European Portuguese - Steps towards the creation of a tool for the application of ICT accessibility requirements in public procurement
    Martins, Marcio
    Godinho, Francisco
    Goncalves, Pedro
    Goncalves, Ramiro
    [J]. 2021 8TH INTERNATIONAL CONFERENCE ON ICT & ACCESSIBILITY (ICTA), 2021,
  • [45] Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
    Hamraz Mokri
    Ingelin Kvamme
    Linda de Vries
    Matthijs Versteegh
    Pieter van Baal
    [J]. The European Journal of Health Economics, 2023, 24 : 701 - 715
  • [46] Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
    Mokri, Hamraz
    Kvamme, Ingelin
    de Vries, Linda
    Versteegh, Matthijs
    van Baal, Pieter
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (05): : 701 - 715
  • [47] COST-EFFECTIVENESS OF AN ANTIBACTERIAL ENVELOPE FOR CARDIAC ELECTRONIC IMPLANTABLE DEVICES IN HIGH-RISK PATIENTS IN THE PUBLIC SECTOR IN MEXICO
    Jauregui Balderrama, V
    Lemus, F.
    Flores, B.
    Figueroa, A.
    Valencia, J.
    Jones, K.
    [J]. VALUE IN HEALTH, 2021, 24 : S124 - S125
  • [48] Use of antibiotic coated intramedullary nails in open tibia fractures: A European medical resource use and cost-effectiveness analysis
    Franz, D.
    Raschke, M.
    Giannoudis, P. V.
    Leliveld, M.
    Metsemakers, W. J.
    Verhofstad, M. H. J.
    Craig, J. A.
    Shore, J.
    Smith, A.
    Muehlendyck, C.
    Kerstan, M.
    Fuchs, T.
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2021, 52 (07): : 1 - 8
  • [49] Cost-effectiveness of uterine balloon tamponade devices in managing atonic post-partum hemorrhage at public health facilities in India
    Joshi, Beena Nitin
    Shetty, Siddesh Sitaram
    Moray, Kusum Venkobrao
    Sachin, Oshima
    Chaurasia, Himanshu
    [J]. PLOS ONE, 2021, 16 (08):
  • [50] Innovative Public Price Mechanisms for Market Access of Innovative Medicines: A Marriage Between Cost-Effectiveness, Medical Need, and Budget Impact
    Annemans, Lieven J. P.
    [J]. VALUE IN HEALTH, 2023, 26 (03) : 400 - 401
12345